Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice

Abstract

Background: Administration of pharmacogenomics (PGx) testing in clinical practice has been suboptimal, presumably due to lack of PGx education. Here, we aim to evaluate the standpoint of PGx testing among a diverse group of healthcare professionals (HCPs) through conducting surveys before and after training.Materials and Methods: Training modules were designed to cover three key learning objectives and deployed in five sections. A pre- and post-training survey questionnaire was used to evaluate participants’ self-assessments on employing PGx in clinical practice.Results and Conclusion: Out of all enrollments, 102 survey responses were collected. Overall, respondents agree on the benefits of PGx testing, but have inadequate self-efficacy and competency in utilizing PGx data. Our results show that a 90 min long training significantly improves these, and could lead to greater anticipation of PGx adoption.

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs

“…However, recent years were witness huge motivations and efforts on overcoming such challenges. Several research groups explored the possibility of adding PGx tests as part of clinical decision systems in hospitals and/or private clinical centers (Adesta et al, 2021). Current policies and activities toward the implementation of PGx for various types of patients in different populations investigated and the pros and cons of the tests have been listed as well (Caraballo et al, 2020;Blagec et al, 2022).…”